PQR626

Item no.	DCC-DC41010-100mg
Manufacturer	DCChemicals
CASRN	1927857-98-4
Amount	100 mg
Category	Inhibitors & Compound Libraries Small Molecules Immunochemistry
Type	Inhibitors
Applications	IC
Specific against	other
Purity	>98%
Smiles	FC([H])(C1=C([H])C(N([H])[H])=NC([H])=C1C1=NC(=NC(=N1)N1[C@]([H])(C([H])([H])[H])C([H])([H])OC([H])([H])[C@]1([H])C([H])([H])[H])N1C([H])([H])C([H])([H])OC([H])([H])[C@@]1([H])C([H])([H])[H])F
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Manufacturer - Applications	PQR626 is an orally available, and brain-penetrant mTOR inhibitor extracted from patent WO2017198346A1, compound example 44, has an IC50 of 5 nM for mTOR. PQR626 can be used for the research of neurological disorder.
Molecular Weight	435, 4709

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 1/29/2026

Express Delivery: Save 6 days

Compare

Add to wishlist

Get an offer